ResearcherNingbo UniversityNo recent work listed

Changjiang Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5756-4593; OpenAlex author ID A5091847582. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Last author DOI 10.1038/s41598-022-16155-w ↗
Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection. Co-author DOI 10.1155/2022/8061879 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Caide Lu · 2 shared papers, 2022 · strength 0.39
- Paper Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in h… DOI 10.1038/s41598-022-16155-w ↗
- Paper Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection. DOI 10.1155/2022/8061879 ↗
Lei Dai · 1 shared paper, 2022 · strength 0.20
- Paper Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in h… DOI 10.1038/s41598-022-16155-w ↗
Jingshu Tong · 1 shared paper, 2022 · strength 0.19
- Paper Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection. DOI 10.1155/2022/8061879 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.